Port Delivery Systems/Devices
The client is a global leader in providing equipment and devices for treating eye-related diseases. Their innovative solutions are designed to meet the needs of eye care professionals worldwide. With a strong focus on research and development, they are committed to improving patient outcomes and providing exceptional customer service and support.
Engagement Objective:
To conduct a technology landscape study to identify the ocular delivery system for the prolonged release of the drug:
- Port delivery systems for the continuous delivery of active agents to the different regions of human eyes
- Alternative technologies for continuous delivery of active agents into eye sites
- Technologies in the pipeline, clinical trials, marketed products
- Players, including companies, universities, research organizations, & startups working on ocular delivery systems of interest
Client Impact:
The study recommendations on delivery systems, polymer materials, release profiles, active agents, and delivery sites helped our client develop ocular delivery systems with the desired release profiles for treating ocular disorders. We recommended various alternative technologies, such as microchip devices with multiple reservoir systems and nano-carriers, to help our client develop promising ocular delivery systems.
Additionally, we suggested promising joint venture opportunities that assisted our client in building connections with players who owned established technologies.
Our clients can gain a competitive edge in the market, boost operational effectiveness, and position themselves as a leader in the area of ocular drug delivery by utilising the study recommendations we made.
